UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis

The Journal of pharmacology and experimental therapeutics, 2012-02, Vol.340 (2), p.350-359

2012

Volltextzugriff (PDF)

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-( N, N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2179-2185

2009

Volltextzugriff (PDF)

Inhibitory effect of carboxylic acid group on hERG binding

Bioorganic & medicinal chemistry letters, 2006-11, Vol.16 (21), p.5507-5512

2006

Volltextzugriff (PDF)

[18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase

Molecular imaging and biology, 2022-10, Vol.24 (5), p.830-841

2022

Volltextzugriff (PDF)

Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors

Bioorganic & medicinal chemistry letters, 2003-02, Vol.13 (3), p.561-566

2003

Volltextzugriff (PDF)

Anthranilamide-based N, N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2186-2189

2009

Volltextzugriff (PDF)

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 3: Design, synthesis and sar of orally bioavailable benzamidine-P4 inhibitors

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1229-1234

2004

Volltextzugriff (PDF)

Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies

Blood, 2023-11, Vol.142 (Supplement 1), p.1887-1887

2023

Volltextzugriff (PDF)

Synthesis of Linear and Angular Triquinane Skeletons by O-Stannyl Ketyl-Promoted Fragmentation−Cyclization Reactions of α-Keto Cyclopropanes

Journal of organic chemistry, 1997-01, Vol.62 (1), p.174-181

1997

Volltextzugriff (PDF)

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 2: A survey of P4 motifs

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1221-1227

2004

Volltextzugriff (PDF)

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.983-987

2004

Volltextzugriff (PDF)

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.989-993

2004

Volltextzugriff (PDF)

Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P1 Structure-activity relationships of the substituted 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides

Bioorganic & medicinal chemistry letters, 2002-06, Vol.12 (12), p.1651-1655

2002

Volltextzugriff (PDF)

N, N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors

Bioorganic & medicinal chemistry letters, 2004-05, Vol.14 (9), p.2073-2078

2004

Volltextzugriff (PDF)

Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors

Arteriosclerosis, thrombosis, and vascular biology, 2003-06, Vol.23 (6), p.1098-1104

2003

Volltextzugriff (PDF)

One- and Two-Electron Reactions from the Rearrangement of α-Ketocyclopropanes by O-Stannyl Ketyls

Journal of organic chemistry, 1997-12, Vol.62 (26), p.9159-9164

1997

Volltextzugriff (PDF)

Abstract 605: ABBV-101, a highly potent and selective clinical stage Bruton tyrosine kinase degrader, overcomes BTK mutation-induced resistance to BTK inhibitors

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.605-605

2024

Volltextzugriff (PDF)

Tetrachlorophthalimido- and Pent-4-enoyl-Protected Glucosamines as Precursors for Preparation of 2-Azido-2-deoxyglucopyranosyl Building Blocks

Journal of organic chemistry, 1998-05, Vol.63 (11), p.3790-3792

1998

Volltextzugriff (PDF)

Reactions of Tin(IV) Enolates and Radicals Derived from the Tin Hydride Scission of Cyclopropyl Ketones

Journal of organic chemistry, 1997-08, Vol.62 (16), p.5248-5249

1997

Volltextzugriff (PDF)

1-(2-Naphthyl)-1 H -pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1229-1234

2004

Volltextzugriff (PDF)

Design, Synthesis, and SAR of Amino Acid Derivatives as Factor Xa Inhibitors

Bioorganic & medicinal chemistry letters, 2001-11, Vol.11 (22), p.2947-2950

2001

Volltextzugriff (PDF)

The Mitsunobu Reaction of Tetrachlorophthalimide

Synlett, 1999-05, Vol.1999 (5), p.565-566

1999

Volltextzugriff (PDF)

Construction of a linear triquinane skeleton by an O-stannyl ketyl radical rearrangement

Chemical communications (Cambridge, England), 1996 (13), p.1567

1996

Volltextzugriff (PDF)

Fragmentation-cyclization reactions of O-stannyl ketyls: The synthesis of an angular triquinane skeleton

Tetrahedron letters, 1996-02, Vol.37 (8), p.1177-1178

1996

Volltextzugriff (PDF)

Ready routes to key myo-inositol component of GPIs employing microbial arene oxidation or Ferrier reaction

Journal of the Chemical Society, Perkin Transactions 1, 1998 (4), p.631-632

1998

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Physical Sciences
(24)
Chemistry
(22)
Chemistry, Organic
(21)
Life Sciences & Biomedicine
(18)
Biological And Medical Sciences
(13)
Factor Xa Inhibitors
(13)
Medical Sciences
(13)
Animals
(12)
Pharmacology & Pharmacy
(12)
Pharmacology. Drug Treatments
(12)
Blood. Blood Coagulation. Reticuloendothelial System
(11)
Chemistry, Medicinal
(11)
Structure-Activity Relationship
(10)
Humans
(9)
Rats
(9)
Drug Design
(7)
Biological Availability
(6)
Administration, Oral
(5)
Rats, Sprague-Dawley
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-( N, N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Inhibitory effect of carboxylic acid group on hERG binding

[18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase

Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors

Anthranilamide-based N, N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 3: Design, synthesis and sar of orally bioavailable benzamidine-P4 inhibitors

Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies

Synthesis of Linear and Angular Triquinane Skeletons by O-Stannyl Ketyl-Promoted Fragmentation−Cyclization Reactions of α-Keto Cyclopropanes

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 2: A survey of P4 motifs

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity

Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P1 Structure-activity relationships of the substituted 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides

N, N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors

Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors

One- and Two-Electron Reactions from the Rearrangement of α-Ketocyclopropanes by O-Stannyl Ketyls

Abstract 605: ABBV-101, a highly potent and selective clinical stage Bruton tyrosine kinase degrader, overcomes BTK mutation-induced resistance to BTK inhibitors

Tetrachlorophthalimido- and Pent-4-enoyl-Protected Glucosamines as Precursors for Preparation of 2-Azido-2-deoxyglucopyranosyl Building Blocks

Reactions of Tin(IV) Enolates and Radicals Derived from the Tin Hydride Scission of Cyclopropyl Ketones

1-(2-Naphthyl)-1 H -pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors

Design, Synthesis, and SAR of Amino Acid Derivatives as Factor Xa Inhibitors

The Mitsunobu Reaction of Tetrachlorophthalimide

Construction of a linear triquinane skeleton by an O-stannyl ketyl radical rearrangement

Fragmentation-cyclization reactions of O-stannyl ketyls: The synthesis of an angular triquinane skeleton

Ready routes to key myo-inositol component of GPIs employing microbial arene oxidation or Ferrier reaction

Suchergebnisse filtern